Detection of JC virus-specific immune responses in a novel humanized mouse model.

Tan CS, Broge TA Jr, Seung E, Vrbanac V, Viscidi R, Gordon J, Tager AM, Koralnik IJ. Detection of JC virus-specific immune responses in a novel humanized mouse model. PLoS One. 2013;8(5):e64313. doi: 10.1371/journal.pone.0064313. Print 2013. PubMed PMID: 23700470; PubMed Central PMCID: PMC3658964.

Multimodal mechanism of action of allosteric HIV-1 integrase inhibitors.

Jurado KA, Engelman A. Multimodal mechanism of action of allosteric HIV-1 integrase inhibitors. Expert Rev Mol Med 2013 Nov 26;15:e14. doi: 10.1017/erm.2013.15. PubMed PMID: 24274067; PubMed Central PMCID: PMC3919682.

Vaccine delivery with microneedle skin patches in nonhuman primates.

DeMuth PC, Li AV, Abbink P, Liu J, Li J, Stanley KA, Smith KM, Lavine CL, Seaman MS, Kramer JA, Miller AD, Abraham W, Suh H, Elkhader J, Hammond PT, Barouch DH, Irvine DJ. Vaccine delivery with microneedle skin patches in nonhuman primates. Nat. Biotech. 2013; 31:1082-1085.

No monkey business: why studying NK cells in non-human primates pays off. Frontiers in Immunology

Hong HS, Rajakumar PA, Billingsley JM, Reeves RK, Johnson RP. No monkey business: why studying NK cells in non-human primates pays off. Frontiers in Immunology. 2013;4. doi:10.3389/fimmu.2013.00032.

Engineering, expression, purification, and characterization of stable clade A/B recombinant soluble heterotrimeric gp140 proteins.

Sellhorn G, Kraft Z, Caldwell Z, Ellingson K, Mineart C, Seaman MS, Montefiori DC, Lagerquist E, Stamatatos L. Engineering, expression, purification, and characterization of stable clade A/B recombinant soluble heterotrimeric gp140 proteins. J. Virol. 2012, 86(1):128-42.

Macaque studies of vaccine and microbicide combinations for preventing HIV-1 sexual transmission.

Barouch DH, Klasse PJ, Dufour J, Veazey RS, Moore JP. Macaque studies of vaccine and microbicide combinations for preventing HIV-1 sexual transmission. Proc. Natl. Acad. Sci. USA 2012; 109:8694-8698.

Vaccine protection against acquisition of neutralization-resistant SIV challenges in rhesus monkeys

Barouch DH, Liu J, Li H, Maxfield LF, Abbink P, Lynch DM, Iampietro MJ, SanMiguel A, Seaman MS, Ferrari G, Forthal DN, Ourmanov I, Hirsch VM, Carville A, Mansfield KG, Stablein D, Pau MG, Schuitemaker H, Sadoff JC, Billings EM, Rao M, Robb ML, Kim JH, Marovich MA, Goudsmit J, Michael NL. Vaccine protection against acquisition of neutralization-resistant SIV challenges in rhesus monkeys. Nature 2012; 482:89-93.

Enhanced HIV-1 neutralization by antibody heteroligation.

Mouquet H, Warncke M, Scheid JF, Seaman MS, Nussenzweig MC. Enhanced HIV-1 neutralization by antibody heteroligation. Proc. Natl. Acad. Sci. 2012, 109(3): 875-80.

Mixed adjuvant formulations reveal a new combination that elicits antibody response comparable to Freund’s adjuvants.

Lai RP, Seaman MS, Tonks P, Wegmann F, Seilly DJ, Frost SD, LaBranche CC, Montefiori DC, Dey AK, Srivastava IK, Sattentau Q, Barnett SW, Heeney JL. Mixed adjuvant formulations reveal a new combination that elicits antibody response comparable to Freund’s adjuvants. PLoS One. 2012, 7(4): e35083.

A mouse model for HIV-1 entry.

Pietzsch J, Gruell H, Bournazos S, Donovan BM, Klein F, Diskin R, Seaman MS, Bjorkman PJ, Ravetch JV, Ploss A, Nussenzweig MC. A mouse model for HIV-1 entry. Proc. Natl. Acad. Sci. 2012, 109(39): 15859-64.